Other studies also showed that AD patient brains display reduced glutamate transporters (GLAST and GLT-1) and vesicular glutamate transporter (VGLUT1; Masliah et al., 1996; Jacob et al., 2007). This evidence concerns the gene SLC1A2 and Alzheimer disease.